Top Markets
#1 Pleasing Gold Pleasing Gold +1,049.05%
#2 PulseChain PulseChain +56.32%
#3 BOOK OF MEME BOOK OF MEME +39.77%
#4 DogBull DogBull +36.97%
#5 Ontology Gas Ontology Gas +31.77%
#6 Neiro Neiro +22.37%
#7 Unit Pump Unit Pump +21.94%
#8 Collect on Fanable Collect on Fanable +19.20%
#9 Pump.fun Pump.fun +18.98%
#10 rsERG rsERG +17.92%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
株式のランク #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
株価
$0.52468396
時価総額
$37.85M
変化（1日）
1.23%
変化（1年）
-4.53%
国
TW
取引 Enimmune corporation (6564)

カテゴリー

Healthcare
Enimmune corporation（6564）のP/B比率
2026 時点のP/B比率 TTM: 0
Enimmune corporation の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Enimmune corporation の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH